Aardvark Therapeutics AARD
NASDAQ AARD
$5.41 +0.06 (+1.12%)
As of: Sep 30, 2026 · 3:28 PM EDT

Aardvark Therapeutics (AARD) Capital Expenditures (2024 - 2025)

Updated

Aardvark Therapeutics' Capital Expenditures was $95,000 in FY2025, down 12.8% from $109,000 in FY2024.

Analysis

Aardvark Therapeutics (AARD) Capital Expenditures (2024 - 2025) Analysis & Trends

  • Per Business Quant data, Capital Expenditures in earlier years was $109,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Aardvark Therapeutics 117.08 Mn 43.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4,000.00
Jun 30, 2025 91,000.00
Dec 31, 2024 6,000.00
Sep 30, 2024 5,000.00
Jun 30, 2024 93,000.00
Mar 31, 2024 5,000.00
API Access

Aardvark Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AARD&period=max&api_key=YOUR_API_KEY